Kenneth Mr. Vercammen was included in the 2017 “Super Lawyers” list published by Thomson Reuters.

To schedule a confidential consultation, email us at, call or visit

(732) 572-0500

Wednesday, August 31, 2016

In re: Reglan Litigation (A-56-14;

 In re: Reglan Litigation (A-56-14; 075269)
          Plaintiffs’ state-law failure-to-warn claims under the
          PLA, based on the alleged inadequate labeling of
          metoclopramide which did not match the brand-name
          labeling and warn of the dangers of the long-term use
          of the drug, are not preempted by federal law, and may
          proceed before the trial court.